Cargando…
Development of non-viral, ligand-dependent, EPHB4-specific chimeric antigen receptor T cells for treatment of rhabdomyosarcoma
Ephrin type-B receptor 4 (EPHB4), expressed in tumors including rhabdomyosarcoma, is a suitable target for chimeric antigen receptor (CAR)-T cells. Ligand-independent activation of EPHB4 causes cell proliferation and malignant transformation in rhabdomyosarcoma, whereas ligand-dependent stimulation...
Autores principales: | Kubo, Hiroshi, Yagyu, Shigeki, Nakamura, Kayoko, Yamashima, Kumiko, Tomida, Akimasa, Kikuchi, Ken, Iehara, Tomoko, Nakazawa, Yozo, Hosoi, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7985479/ https://www.ncbi.nlm.nih.gov/pubmed/33816783 http://dx.doi.org/10.1016/j.omto.2021.03.001 |
Ejemplares similares
-
Inhibition of MEK pathway enhances the antitumor efficacy of chimeric antigen receptor T cells against neuroblastoma
por: Tomida, Akimasa, et al.
Publicado: (2021) -
Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
por: Ouchi, Kazutaka, et al.
Publicado: (2020) -
In ovo chorioallantoic membrane assay as a xenograft model for pediatric rhabdomyosarcoma
por: Shoji, Chika, et al.
Publicado: (2023) -
Reduced B7-H3 expression by PAX3-FOXO1 knockdown inhibits cellular motility and promotes myogenic differentiation in alveolar rhabdomyosarcoma
por: Kanayama, Takuyo, et al.
Publicado: (2021) -
OBP-801, a novel histone deacetylase inhibitor, induces M-phase arrest and apoptosis in rhabdomyosarcoma cells
por: Tomoyasu, Chihiro, et al.
Publicado: (2019)